Orionisbio
2 known investors
Orions Bio discovers, designs and engineers molecules that connect proteins on and within cells to reprogram disease-driving processes or activate immune responses. The company develops small molecule drugs, conditionally active cytokines, and multimodal cell engagers for cancer, autoimmune diseases, and neurodegenerative disorders.
BiotechDeep TechHealthtech